phase readout
saveNCT06066957: Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
RECRUITINGupdated 11d ago
community read0 votes
Sponsor: University of Pennsylvania. Phase: PHASE2. Conditions: Cytomegalovirus Infections, Transplant-Related Disorder
view source ↗
comments(0)
5-min edit window · permanent after that